APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticoagulant Reversal Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anticoagulant Reversal Medicine Market Analysis and Forecast 2026-2032

1 January 2026197 pages

Choose your research edition.

Industry ResearchAnticoagulant Reversal Medicine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticoagulant Reversal Medicine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Anticoagulant Reversal Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticoagulant Reversal Medicine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticoagulant Reversal Medicine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anticoagulant Reversal Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Anticoagulant Reversal Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anticoagulant Reversal Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anticoagulant Reversal Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anticoagulant Reversal Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Anticoagulant Reversal Medicine include Pfizer, Fresenius Kabi, Portola Pharmaceuticals, Perosphere Pharmaceuticals, Octapharma, CSL, Boehringer Ingelheim, Bausch Health Companies and Amneal Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Anticoagulant Reversal Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anticoagulant Reversal Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Anticoagulant Reversal Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anticoagulant Reversal Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anticoagulant Reversal Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anticoagulant Reversal Medicine revenue, projected growth trends, production technology, application and end-user industry.

Anticoagulant Reversal Medicine Segment by Company

Pfizer

Fresenius Kabi

Portola Pharmaceuticals

Perosphere Pharmaceuticals

Octapharma

CSL

Boehringer Ingelheim

Bausch Health Companies

Amneal Pharmaceuticals

Anticoagulant Reversal Medicine Segment by Type

Phytonadione

Coagulation Factors

Prothrombin Complex Concentrates

Monoclonal Antibodies

Others

Anticoagulant Reversal Medicine Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Anticoagulant Reversal Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulant Reversal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticoagulant Reversal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulant Reversal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anticoagulant Reversal Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anticoagulant Reversal Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticoagulant Reversal Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anticoagulant Reversal Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Phytonadione Major Player Table 3. Coagulation Factors Major Player Table 4. Prothrombin Complex Concentrates Major Player Table 5. Monoclonal Antibodies Major Player Table 6. Others Major Player Table 7. Global Anticoagulant Reversal Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Retail Pharmacies Major Player Table 9. Online Pharmacies Major Player Table 10. Hospital Pharmacies Major Player Table 11. Anticoagulant Reversal Medicine Industry Trends Table 12. Anticoagulant Reversal Medicine Industry Drivers Table 13. Anticoagulant Reversal Medicine Industry Opportunities and Challenges Table 14. Anticoagulant Reversal Medicine Industry Restraints Table 15. Global Anticoagulant Reversal Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Anticoagulant Reversal Medicine Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Anticoagulant Reversal Medicine Market Share by Region (2021-2026) Table 18. Global Anticoagulant Reversal Medicine Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Anticoagulant Reversal Medicine Market Share by Region (2027-2032) Table 20. Global Anticoagulant Reversal Medicine Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Anticoagulant Reversal Medicine Revenue Market Share by Players (2021-2026) Table 22. Global Anticoagulant Reversal Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Anticoagulant Reversal Medicine Key Players Headquarters & Area Served Table 24. Global Anticoagulant Reversal Medicine Players, Product Type & Application Table 25. Global Anticoagulant Reversal Medicine Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Anticoagulant Reversal Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Anticoagulant Reversal Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Anticoagulant Reversal Medicine Revenue Market Share by Type (2021-2026) Table 32. Global Anticoagulant Reversal Medicine Revenue Market Share by Type (2027-2032) Table 33. Global Anticoagulant Reversal Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Anticoagulant Reversal Medicine Revenue Market Share by Application (2021-2026) Table 37. Global Anticoagulant Reversal Medicine Revenue Market Share by Application (2027-2032) Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Pfizer Anticoagulant Reversal Medicine Product Portfolio Table 42. Pfizer Recent Development Table 43. Fresenius Kabi Company Information Table 44. Fresenius Kabi Business Overview Table 45. Fresenius Kabi Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Fresenius Kabi Anticoagulant Reversal Medicine Product Portfolio Table 47. Fresenius Kabi Recent Development Table 48. Portola Pharmaceuticals Company Information Table 49. Portola Pharmaceuticals Business Overview Table 50. Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Portola Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio Table 52. Portola Pharmaceuticals Recent Development Table 53. Perosphere Pharmaceuticals Company Information Table 54. Perosphere Pharmaceuticals Business Overview Table 55. Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio Table 57. Perosphere Pharmaceuticals Recent Development Table 58. Octapharma Company Information Table 59. Octapharma Business Overview Table 60. Octapharma Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Octapharma Anticoagulant Reversal Medicine Product Portfolio Table 62. Octapharma Recent Development Table 63. CSL Company Information Table 64. CSL Business Overview Table 65. CSL Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. CSL Anticoagulant Reversal Medicine Product Portfolio Table 67. CSL Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Boehringer Ingelheim Anticoagulant Reversal Medicine Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Bausch Health Companies Company Information Table 74. Bausch Health Companies Business Overview Table 75. Bausch Health Companies Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Bausch Health Companies Anticoagulant Reversal Medicine Product Portfolio Table 77. Bausch Health Companies Recent Development Table 78. Amneal Pharmaceuticals Company Information Table 79. Amneal Pharmaceuticals Business Overview Table 80. Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Amneal Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio Table 82. Amneal Pharmaceuticals Recent Development Table 83. North America Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Anticoagulant Reversal Medicine Revenue by Country (2021-2026) & (US$ Million) Table 89. North America Anticoagulant Reversal Medicine Revenue by Country (US$ Million) & (2027-2032) Table 90. Europe Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe Anticoagulant Reversal Medicine Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Anticoagulant Reversal Medicine Revenue by Country (US$ Million) & (2027-2032) Table 97. China Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 98. China Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 99. China Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 100. China Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 102. Asia Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 103. Asia Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 104. Asia Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Anticoagulant Reversal Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia Anticoagulant Reversal Medicine Revenue by Region (US$ Million) & (2021-2026) Table 107. Asia Anticoagulant Reversal Medicine Revenue by Region (US$ Million) & (2027-2032) Table 108. SAMEA Anticoagulant Reversal Medicine Revenue by Type (2021-2026) & (US$ Million) Table 109. SAMEA Anticoagulant Reversal Medicine Revenue by Type (2027-2032) & (US$ Million) Table 110. SAMEA Anticoagulant Reversal Medicine Revenue by Application (2021-2026) & (US$ Million) Table 111. SAMEA Anticoagulant Reversal Medicine Revenue by Application (2027-2032) & (US$ Million) Table 112. SAMEA Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. SAMEA Anticoagulant Reversal Medicine Revenue by Country (2021-2026) & (US$ Million) Table 114. SAMEA Anticoagulant Reversal Medicine Revenue by Country (US$ Million) & (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Anticoagulant Reversal Medicine Image Figure 2. Global Anticoagulant Reversal Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anticoagulant Reversal Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Phytonadione Image Figure 5. Coagulation Factors Image Figure 6. Prothrombin Complex Concentrates Image Figure 7. Monoclonal Antibodies Image Figure 8. Others Image Figure 9. Global Anticoagulant Reversal Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Anticoagulant Reversal Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global Anticoagulant Reversal Medicine Market Size (US$ Million) & (2021-2032) Figure 15. Global Anticoagulant Reversal Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Anticoagulant Reversal Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Anticoagulant Reversal Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Anticoagulant Reversal Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Anticoagulant Reversal Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Anticoagulant Reversal Medicine Revenue Market Share by Type (2021-2032) Figure 22. Global Anticoagulant Reversal Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Anticoagulant Reversal Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Anticoagulant Reversal Medicine Revenue Market Share by Application (2021-2032) Figure 25. North America Anticoagulant Reversal Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032) Figure 27. North America Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032) Figure 28. North America Anticoagulant Reversal Medicine Revenue Share by Country (2021-2032) Figure 29. United States Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Anticoagulant Reversal Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032) Figure 34. Europe Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032) Figure 35. Europe Anticoagulant Reversal Medicine Revenue Share by Country (2021-2032) Figure 36. Germany Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Anticoagulant Reversal Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032) Figure 46. China Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032) Figure 47. Asia Anticoagulant Reversal Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032) Figure 49. Asia Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032) Figure 50. Asia Anticoagulant Reversal Medicine Revenue Share by Region (2021-2032) Figure 51. Japan Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Anticoagulant Reversal Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032) Figure 59. SAMEA Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032) Figure 60. SAMEA Anticoagulant Reversal Medicine Revenue Share by Country (2021-2032) Figure 61. Brazil Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Anticoagulant Reversal Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Phytonadione
  • Coagulation Factors
  • Prothrombin Complex Concentrates
  • Monoclonal Antibodies
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Portola Pharmaceuticals
  • Perosphere Pharmaceuticals
  • Octapharma
  • CSL
  • Boehringer Ingelheim
  • Bausch Health Companies
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anticoagulant Reversal Medicine Market by Type
  3. 1.2.1 Global Anticoagulant Reversal Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Phytonadione
  5. 1.2.3 Coagulation Factors
  6. 1.2.4 Prothrombin Complex Concentrates
  7. 1.2.5 Monoclonal Antibodies
  8. 1.2.6 Others
  9. 1.3 Anticoagulant Reversal Medicine Market by Application
  10. 1.3.1 Global Anticoagulant Reversal Medicine Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Anticoagulant Reversal Medicine Market Dynamics
  1. 2.1 Anticoagulant Reversal Medicine Industry Trends
  2. 2.2 Anticoagulant Reversal Medicine Industry Drivers
  3. 2.3 Anticoagulant Reversal Medicine Industry Opportunities and Challenges
  4. 2.4 Anticoagulant Reversal Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anticoagulant Reversal Medicine Market Perspective (2021-2032)
  2. 3.2 Global Anticoagulant Reversal Medicine Growth Trends by Region
  3. 3.2.1 Global Anticoagulant Reversal Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anticoagulant Reversal Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Anticoagulant Reversal Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anticoagulant Reversal Medicine Revenue by Players
  2. 4.1.1 Global Anticoagulant Reversal Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Anticoagulant Reversal Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anticoagulant Reversal Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anticoagulant Reversal Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anticoagulant Reversal Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Anticoagulant Reversal Medicine Players, Product Type & Application
  8. 4.5 Global Anticoagulant Reversal Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anticoagulant Reversal Medicine Market CR5 and HHI
  11. 4.6.3 2025 Anticoagulant Reversal Medicine Tier 1, Tier 2, and Tier 3
5 Anticoagulant Reversal Medicine Market Size by Type
  1. 5.1 Global Anticoagulant Reversal Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Anticoagulant Reversal Medicine Revenue Market Share by Type (2021-2032)
6 Anticoagulant Reversal Medicine Market Size by Application
  1. 6.1 Global Anticoagulant Reversal Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Anticoagulant Reversal Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Anticoagulant Reversal Medicine Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Fresenius Kabi
  8. 7.2.1 Fresenius Kabi Company Information
  9. 7.2.2 Fresenius Kabi Business Overview
  10. 7.2.3 Fresenius Kabi Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Fresenius Kabi Anticoagulant Reversal Medicine Product Portfolio
  12. 7.2.5 Fresenius Kabi Recent Developments
  13. 7.3 Portola Pharmaceuticals
  14. 7.3.1 Portola Pharmaceuticals Company Information
  15. 7.3.2 Portola Pharmaceuticals Business Overview
  16. 7.3.3 Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Portola Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio
  18. 7.3.5 Portola Pharmaceuticals Recent Developments
  19. 7.4 Perosphere Pharmaceuticals
  20. 7.4.1 Perosphere Pharmaceuticals Company Information
  21. 7.4.2 Perosphere Pharmaceuticals Business Overview
  22. 7.4.3 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio
  24. 7.4.5 Perosphere Pharmaceuticals Recent Developments
  25. 7.5 Octapharma
  26. 7.5.1 Octapharma Company Information
  27. 7.5.2 Octapharma Business Overview
  28. 7.5.3 Octapharma Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Octapharma Anticoagulant Reversal Medicine Product Portfolio
  30. 7.5.5 Octapharma Recent Developments
  31. 7.6 CSL
  32. 7.6.1 CSL Company Information
  33. 7.6.2 CSL Business Overview
  34. 7.6.3 CSL Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CSL Anticoagulant Reversal Medicine Product Portfolio
  36. 7.6.5 CSL Recent Developments
  37. 7.7 Boehringer Ingelheim
  38. 7.7.1 Boehringer Ingelheim Company Information
  39. 7.7.2 Boehringer Ingelheim Business Overview
  40. 7.7.3 Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Boehringer Ingelheim Anticoagulant Reversal Medicine Product Portfolio
  42. 7.7.5 Boehringer Ingelheim Recent Developments
  43. 7.8 Bausch Health Companies
  44. 7.8.1 Bausch Health Companies Company Information
  45. 7.8.2 Bausch Health Companies Business Overview
  46. 7.8.3 Bausch Health Companies Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bausch Health Companies Anticoagulant Reversal Medicine Product Portfolio
  48. 7.8.5 Bausch Health Companies Recent Developments
  49. 7.9 Amneal Pharmaceuticals
  50. 7.9.1 Amneal Pharmaceuticals Company Information
  51. 7.9.2 Amneal Pharmaceuticals Business Overview
  52. 7.9.3 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Product Portfolio
  54. 7.9.5 Amneal Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Anticoagulant Reversal Medicine Revenue (2021-2032)
  2. 8.2 North America Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Anticoagulant Reversal Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Anticoagulant Reversal Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Anticoagulant Reversal Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Anticoagulant Reversal Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Anticoagulant Reversal Medicine Revenue by Country
  11. 8.6.1 North America Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anticoagulant Reversal Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Anticoagulant Reversal Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Anticoagulant Reversal Medicine Revenue (2021-2032)
  2. 9.2 Europe Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anticoagulant Reversal Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anticoagulant Reversal Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anticoagulant Reversal Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anticoagulant Reversal Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anticoagulant Reversal Medicine Revenue by Country
  11. 9.6.1 Europe Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anticoagulant Reversal Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anticoagulant Reversal Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Anticoagulant Reversal Medicine Revenue (2021-2032)
  2. 10.2 China Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Anticoagulant Reversal Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Anticoagulant Reversal Medicine Revenue by Type (2027-2032)
  5. 10.3 China Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Anticoagulant Reversal Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Anticoagulant Reversal Medicine Revenue by Application (2027-2032)
  9. 10.5 China Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anticoagulant Reversal Medicine Revenue (2021-2032)
  2. 11.2 Asia Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anticoagulant Reversal Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anticoagulant Reversal Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anticoagulant Reversal Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anticoagulant Reversal Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anticoagulant Reversal Medicine Revenue by Country
  11. 11.6.1 Asia Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anticoagulant Reversal Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anticoagulant Reversal Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anticoagulant Reversal Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Anticoagulant Reversal Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anticoagulant Reversal Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anticoagulant Reversal Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anticoagulant Reversal Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anticoagulant Reversal Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anticoagulant Reversal Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anticoagulant Reversal Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anticoagulant Reversal Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anticoagulant Reversal Medicine Revenue by Country
  11. 12.6.1 SAMEA Anticoagulant Reversal Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anticoagulant Reversal Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anticoagulant Reversal Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst